Emily O. Dumas

Opioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic Perspective

Emily O. Dumas, Gary M. Pollack · The AAPS Journal · 2008 · 265 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection

Nancy Reau, Paul Y. Kwo, Susan Rhee et al. · Hepatology · 2018 · 181 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A

David A. DeGoey, John T. Randolph, Dachun Liu et al. · Journal of Medicinal Chemistry · 2014 · 126 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1–6 infection

Nancy Reau, P. Kwo, Susan Rhee et al. · Journal of Hepatology · 2017 · 55 citations

Medicine, Infectious Diseases, Pharmacotherapy +16

Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial

Tania M. Welzel, Tarik Asselah, Emily O. Dumas et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 50 citations

Medicine, Infectious Diseases, Pharmacotherapy +14